Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis

被引：0
作者：
Giuseppe Rosiello
Carlotta Palumbo
Sophie Knipper
Angela Pecoraro
Stefano Luzzago
Pierre-Antoine St-Hilaire
Zhe Tian
Umberto Capitanio
Francesco Montorsi
Shahrokh F. Shariat
Fred Saad
Alberto Briganti
Pierre I. Karakiewicz
机构：
[1] University of Montreal Health Center,Cancer Prognostics and Health Outcomes Unit, Division of Urology
[2] IRCCS San Raffaele Scientific Institute,Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute
[3] University of Brescia,Urology Unit, ASST Spedali Civili of Brescia, Department of Medical and Surgical Specialties, Radiological Science and Public Health
[4] University Hospital Hamburg-Eppendorf,Martini
[5] University of Turin,Klinik Prostate Cancer Center
[6] European Institute of Oncology,Department of Urology, San Luigi Gonzaga Hospital
[7] Medical University of Vienna,Department of Urology
[8] I.M. Sechenov First Moscow State Medical University,Department of Urology, Comprehensive Cancer Center
来源：
World Journal of Urology | 2021年 / 39卷
关键词：
Combination therapy; Cytoreductive nephrectomy; Histology; Kidney cancer; SEER database; Targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：461 / 472
页数：11
相关论文
共 139 条
[1]  
Störkel S(1997)Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC) Cancer 80 987-989
[2]  
Eble JN(2019)Clinical stage migration and survival for renal cell carcinoma in the United States Eur Urol Oncol 2 343-348
[3]  
Adlakha K(2005)Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience J Clin Oncol 23 2763-2771
[4]  
Amin M(2010)Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma J Urol 183 1309-1316
[5]  
Blute ML(2003)Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma Am J Surg Pathol 27 612-624
[6]  
Bostwick DG(2017)Characterizing the outcomes of metastatic papillary renal cell carcinoma Cancer Med 6 902-909
[7]  
Patel HD(2016)Papillary type 2 versus clear cell renal cell carcinoma: Survival outcomes Eur J Surg Oncol EJSO 42 1744-1750
[8]  
Gupta M(2016)Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery World J Urol 34 687-693
[9]  
Joice GA(2002)Kidney pathology: current classification of renal cell carcinoma Curr Urol Rep 3 25-30
[10]  
Srivastava A(2019)Individualised indications for cytoreductive nephrectomy: which criteria define the optimal candidates? Eur Urol Oncol 2 365-378
12345678910